Casdin Capital
Casdin Capital is a specialized investment firm focused on the life sciences. The firm invests across Healthcare, Biotechnology, Synthetic Biology and Technology by partnering with companies, building positions, and providing strategic and private partnership investments. Casdin emphasizes data-driven approaches, sector expertise, and a multi-year investment horizon.
Casdin Capital
New York, New York, United States, North America
Services
Strategic equity investments
Carefully fund companies through strategic equity investments and by building positions in life sciences companies.
Private partnerships
Structure private partnerships and co-investment arrangements with select companies and partners.
Sector-focused deal sourcing and partnering
Partner with companies across targeted life-science sectors to identify opportunities and create value through long-term engagement.
Strategic equity investments
Carefully fund companies through strategic equity investments and by building positions in life sciences companies.
Private partnerships
Structure private partnerships and co-investment arrangements with select companies and partners.
Sector-focused deal sourcing and partnering
Partner with companies across targeted life-science sectors to identify opportunities and create value through long-term engagement.
Portfolio
Listed as a venture in Casdin's portfolio; described as part of biotechnology focus.
#Biotechnology / Consumer genomics
Engineered over 1 billion viral vectors; expanding cGMP manufacturing; capabilities in vivo and ex vivo.
#Gene therapy / Biotechnology
Devices use molecular traps much smaller than those in conventional mass spectrometers.
#Life science tools / Analytical instrumentation
Engineers T cells to target solid tumors with a platform combining activators and blockers to improve selectivity.
#Cell therapy / Biotechnology
Based in Vancouver, WA; leverages metabolic strain laboratory culture, bioprocessing and purification methods to increase efficiency and reduce cost of pharmaceutical development.
#Bioprocessing / Biopharmaceuticals
Develops platforms translating the adaptive immune system into diagnostic and therapeutic applications.
#Immunology / Diagnostics
Listed as a venture in Casdin's portfolio; described as part of biotechnology focus.
#Biotechnology / Consumer genomics
Engineered over 1 billion viral vectors; expanding cGMP manufacturing; capabilities in vivo and ex vivo.
#Gene therapy / Biotechnology
Devices use molecular traps much smaller than those in conventional mass spectrometers.
#Life science tools / Analytical instrumentation
Engineers T cells to target solid tumors with a platform combining activators and blockers to improve selectivity.
#Cell therapy / Biotechnology
Based in Vancouver, WA; leverages metabolic strain laboratory culture, bioprocessing and purification methods to increase efficiency and reduce cost of pharmaceutical development.
#Bioprocessing / Biopharmaceuticals
Develops platforms translating the adaptive immune system into diagnostic and therapeutic applications.
#Immunology / Diagnostics